Screener
Rapport Therapeutics, Inc. RAPP Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Rapport Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
FAQ
- What is Rapport Therapeutics, Inc.'s current ratio?
- Rapport Therapeutics, Inc. (RAPP) reported current ratio of 15.7× in Q2 2026.
- How has Rapport Therapeutics, Inc.'s current ratio changed year-over-year?
- Rapport Therapeutics, Inc.'s current ratio decreased by 30.9% year-over-year, from 22.7× to 15.7×.
- What is the long-term trend for Rapport Therapeutics, Inc.'s current ratio?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s current ratio has grown at a 23.6% compound annual growth rate (CAGR), from 17.1× to 26.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Rapport Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude